Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Tonouchi

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Advances in Experimental Medicine and Biology|April 24, 2020
Memory B Cells in Local and Systemic SitesSaya Moriyama, Yu Adachi, Keisuke Tonouchi, et al.
International Immunology|June 7, 2020
Stereotyped B-cell response that counteracts antigenic variation of influenza virusesKeisuke Tonouchi, Yu Adachi, Saya Moriyama, et al.
Plos Pathogens|August 9, 2023
Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitopeKeisuke Tonouchi, Yu Adachi, Tateki Suzuki, et al.
Vaccine|June 17, 2023
Post-fusion influenza vaccine adjuvanted with SA-2 confers heterologous protection via Th1-polarized, non-neutralizing antibody responsesAyae Nishiyama, Yu Adachi, Keisuke Tonouchi, et al.
Frontiers in Immunology|December 8, 2025
On the carrying capacity of the bone marrow survival niche in miceKeisuke Tonouchi, Chen-Hao Yeh, Derek W Cain, et al.
Iscience|August 22, 2022
SARS-CoV-2-specific CD4<sup>+</sup> T cell longevity correlates with Th17-like phenotypeKazutaka Terahara, Takashi Sato, Yu Adachi, et al.
Nature Communications|June 19, 2021
Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cellsKosuke Miyauchi, Yu Adachi, Keisuke Tonouchi, et al.
Cell Reports. Medicine|May 11, 2022
Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccineTomohiro Takano, Miwa Morikawa, Yu Adachi, et al.
Nature Communications|August 30, 2019
Exposure of an occluded hemagglutinin epitope drives selection of a class of cross-protective influenza antibodiesYu Adachi, Keisuke Tonouchi, Arnone Nithichanon, et al.
Science Immunology|February 3, 2022
SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccineRyutaro Kotaki, Yu Adachi, Saya Moriyama, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|April 24, 2020
Memory B Cells in Local and Systemic SitesSaya Moriyama, Yu Adachi, Keisuke Tonouchi, et al.
International Immunology|June 7, 2020
Stereotyped B-cell response that counteracts antigenic variation of influenza virusesKeisuke Tonouchi, Yu Adachi, Saya Moriyama, et al.
Plos Pathogens|August 9, 2023
Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitopeKeisuke Tonouchi, Yu Adachi, Tateki Suzuki, et al.
Vaccine|June 17, 2023
Post-fusion influenza vaccine adjuvanted with SA-2 confers heterologous protection via Th1-polarized, non-neutralizing antibody responsesAyae Nishiyama, Yu Adachi, Keisuke Tonouchi, et al.
Frontiers in Immunology|December 8, 2025
On the carrying capacity of the bone marrow survival niche in miceKeisuke Tonouchi, Chen-Hao Yeh, Derek W Cain, et al.
Iscience|August 22, 2022
SARS-CoV-2-specific CD4<sup>+</sup> T cell longevity correlates with Th17-like phenotypeKazutaka Terahara, Takashi Sato, Yu Adachi, et al.
Nature Communications|June 19, 2021
Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cellsKosuke Miyauchi, Yu Adachi, Keisuke Tonouchi, et al.
Cell Reports. Medicine|May 11, 2022
Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccineTomohiro Takano, Miwa Morikawa, Yu Adachi, et al.
Nature Communications|August 30, 2019
Exposure of an occluded hemagglutinin epitope drives selection of a class of cross-protective influenza antibodiesYu Adachi, Keisuke Tonouchi, Arnone Nithichanon, et al.
Science Immunology|February 3, 2022
SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccineRyutaro Kotaki, Yu Adachi, Saya Moriyama, et al.
Pageof 2